RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding RVL Pharmaceuticals plc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 31 | 36 | +5 |
| Shares | 17.3M | 16.4M | −861.3K (−5.0%) |
| Value | $18.7M | $27.8M | +$9.13M (+48.9%) |
New holders (10)
Institutions that held RVL Pharmaceuticals plc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marietta Wealth Management, LLC | 120,000 | $203.0K | 0.04% |
| Atria Wealth Solutions, Inc. | 35,400 | $60.0K | 0.00% |
| Charles Schwab Investment Management Inc | 32,713 | $56.0K | 0.00% |
| Parametric Portfolio Associates LLC | 19,020 | $32.0K | 0.00% |
| Susquehanna International Group, LLP | 10,954 | $19.0K | 0.00% |
| Williams Jones Wealth Management, LLC. | 10,000 | $17.0K | 0.00% |
| Tower View Investment Management & Research LLC | 4,100 | $7.00K | 0.00% |
| Group One Trading, L.P. | 2,000 | $3.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 107 | $181 | 0.00% |
| Northwestern Mutual Wealth Management Co | 275 | $0 | 0.00% |
Sold out (5)
Institutions that held RVL Pharmaceuticals plc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 1,125,689 | $1.22M |
| Deutsche Bank AG | 70,524 | $76.0K |
| Millennium Management LLC | 43,560 | $47.0K |
| Zebra Capital Management LLC | 24,384 | $26.0K |
| Simplex Trading, LLC | 2,298 | $2.00K |